- Home
- TENX vs NRXS Comparison
TENX vs NRXS Comparison
Compare TENX & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- NRXS
- Stock Information
- Founded
- TENX 1967
- NRXS 2011
- Country
- TENX United States
- NRXS United States
- Employees
- TENX N/A
- NRXS N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- NRXS
- Sector
- TENX Health Care
- NRXS
- Exchange
- TENX Nasdaq
- NRXS Nasdaq
- Market Cap
- TENX 31.9M
- NRXS 25.8M
- IPO Year
- TENX N/A
- NRXS 2023
- Fundamental
- Price
- TENX $7.70
- NRXS $2.52
- Analyst Decision
- TENX Strong Buy
- NRXS Strong Buy
- Analyst Count
- TENX 2
- NRXS 1
- Target Price
- TENX $17.00
- NRXS $7.00
- AVG Volume (30 Days)
- TENX 59.3K
- NRXS 1.1M
- Earning Date
- TENX 11-12-2025
- NRXS 11-10-2025
- Dividend Yield
- TENX N/A
- NRXS N/A
- EPS Growth
- TENX N/A
- NRXS N/A
- EPS
- TENX N/A
- NRXS N/A
- Revenue
- TENX N/A
- NRXS $3,362,320.00
- Revenue This Year
- TENX N/A
- NRXS $50.75
- Revenue Next Year
- TENX N/A
- NRXS $130.50
- P/E Ratio
- TENX N/A
- NRXS N/A
- Revenue Growth
- TENX N/A
- NRXS 36.89
- 52 Week Low
- TENX $4.63
- NRXS $1.33
- 52 Week High
- TENX $8.24
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- TENX 60.46
- NRXS 42.77
- Support Level
- TENX $7.30
- NRXS $2.26
- Resistance Level
- TENX $8.05
- NRXS $2.62
- Average True Range (ATR)
- TENX 0.43
- NRXS 0.21
- MACD
- TENX 0.05
- NRXS -0.01
- Stochastic Oscillator
- TENX 79.87
- NRXS 61.11
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).